Perioperative levetiracetam for seizure prophylaxis in seizure-naive brain tumor patients with focus on neurocognitive functioning

INTRODUCTION: In seizure-naive brain tumor patients, the efficacy of perioperative prophylactic antiepileptic drug treatment remains controversial. In case of administration, the common preferred drug is levetiracetam (LEV) because of its favorable pharmacological profile. Research to date has not s...

Descripción completa

Detalles Bibliográficos
Autores principales: Konrath, Elias, Marhold, Franz, Kindler, Wolfgang, Scheichel, Florian, Popadic, Branko, Blauensteiner, Katrin, Calabek, Bernadette, Freydl, Elisabeth, Weber, Michael, Ristl, Robin, Hainz, Katharina, Sherif, Camillo, Oberndorfer, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264633/
https://www.ncbi.nlm.nih.gov/pubmed/35804291
http://dx.doi.org/10.1186/s12883-022-02762-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264633/
https://www.ncbi.nlm.nih.gov/pubmed/35804291
http://dx.doi.org/10.1186/s12883-022-02762-7

Ejemplares similares